Odyssean »

Camden National Corporation shares owned by Odyssean

Quarter-by-quarter ownership of Camden National Corporation (CAC) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Camden National Corporation

Tip: Access up to 7 years of quarterly data

All positions including Camden National Corporation held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Camden National Corporation by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $244k 4.5k 54.22

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Camden National Corporation

BlackRock
Franklin Resources
FMR
Dimensional Fund Advisors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
American Century Companies
Basswood Capital Management
Manufacturers Life Insurance Company
Jpmorgan Chase & Co
Renaissance Technologies
Wellington Management Company
Hotchkis and Wiley Capital Management
LSV Asset Management

View all funds holding Camden National Corporation